Anti-cancer

Mitomycin C

CAS No. 50-07-7

An alkylating antitumor antibiotic used in injectable and intravesical oncology formulations, including for bladder and gastrointestinal cancers.

Mitomycin C is a fermentation-derived antitumor antibiotic API manufactured by NovaAcura Biotech under strict GMP conditions appropriate to cytotoxic API handling. Full batch documentation and regulatory support are available for global oncology formulation partners.

Applications & Uses

An alkylating antitumor antibiotic used in injectable and intravesical oncology formulations, including for bladder and gastrointestinal cancers.

Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.

Need This Molecule at Scale?

Get in touch for pricing, lead times and full regulatory documentation.

Get In Touch